For decades, stimulant medications like methylphenidate (Ritalin) and amphetamine derivatives (Adderall) have been the primary medical treatment for ADHD. These medications increase dopamine and norepinephrine activity in the brain, temporarily improving focus and impulse control. However, medications typically work only while the drug is active in the body and may cause side effects such as sleep disruption, appetite suppression, and emotional instability.
Neurofeedback takes a different approach. Instead of altering neurotransmitters chemically, it trains the brain to regulate its own electrical activity. During neurofeedback sessions, EEG sensors monitor brainwave patterns while real-time visual or auditory feedback rewards healthier neural patterns.
Over the last 30 years, numerous randomized controlled trials and meta-analyses have evaluated neurofeedback for ADHD.
A large systematic review published in Neuroscience & Biobehavioral Reviews found that EEG neurofeedback significantly improved ADHD symptoms including inattention and impulsivity, particularly when standard protocols such as theta/beta training were used.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9762555/
Another meta-analysis published in Clinical EEG and Neuroscience concluded that neurofeedback produced medium-to-large improvements in attention and hyperactivity symptoms compared with control groups.
https://pubmed.ncbi.nlm.nih.gov/19715181/
Research comparing neurofeedback with stimulant medication also shows promising results. A controlled study reported that neurofeedback achieved symptom reductions comparable to methylphenidate, with benefits persisting months after training ended.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4892322/
Unlike medication, neurofeedback may lead to long-term brain changes through neuroplasticity, potentially explaining why improvements often remain after treatment ends.
